DXCM Dexcom
Nasdaq · SEC CIK 1093557 · EDGAR
- Bought, last 12 months
- $1.00M 1 purchases by 1 insiders
- Sold, last 12 months
- $12.40M 23 sales by 9 insiders
- Filings on record
- 365 since 2021-07-08, latest 2026-09-16 16:26
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| SAYER KEVIN R | Executive COB, Dir | — | $8.30M |
| Leach Jacob Steven | Pres, COO | $1.00M | — |
| Brown Michael Jon | EVP, CLO | — | $873.4K |
| Coleman Jon | EVP, Chief Commercial Off | — | $722.6K |
| AUGUSTINOS NICHOLAS | Dir | — | $679.8K |
| FOLETTA MARK G | Dir | — | $627.2K |
| Collins Richard Alexander | Dir | — | $389.4K |
| Sylvain Jereme M | EVP, Chief Financal Off | — | $302.9K |
| Heller Bridgette P | Dir | — | $277.7K |
| Stern Sadie | EVP, Chief HR Off | — | $226.7K |
Transactions 461
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-03-14 | 2023-03-10 | DXCM | Dolan Matthew Vincent | SVP Corp. Strategy-Develop | D - Sale to Iss | $111.40 | -6,204 | 46.9K | -12% | -$691.1K |
| 2023-03-10 | 2023-03-08 | DXCM | Stern Sadie | EVP Chief Human Resources Offi | A - Grant | $0.00 | +21.8K | 90.2K | +32% | $0 | |
| 2023-03-10 | 2023-03-08 | DXCM | SAYER KEVIN R | Pres CEO, COB of, Dir | A - Grant | $0.00 | +54.4K | 385.8K | +16% | $0 | |
| 2023-03-10 | 2023-03-08 | DXCM | Pacelli Steven Robert | EVP Managing Dir Dexcom V | A - Grant | $0.00 | +18.8K | 155.2K | +14% | $0 | |
| 2023-03-10 | 2023-03-08 | DXCM | Sylvain Jereme M | EVP CFO | A - Grant | $0.00 | +21.8K | 86.7K | +34% | $0 | |
| 2023-03-10 | 2023-03-08 | DXCM | Lawver Teri L | EVP Chief Commercial Off | A - Grant | $0.00 | +45.4K | 45.4K | New | $0 | |
| 2023-03-10 | 2023-03-08 | DXCM | Regan Barry J. | EVP Ops | A - Grant | $0.00 | +18.8K | 78.2K | +32% | $0 | |
| 2023-03-10 | 2023-03-08 | DXCM | Naganathan Girish | EVP CTO | A - Grant | $0.00 | +18.8K | 50.2K | +60% | $0 | |
| 2023-03-10 | 2023-03-08 | DXCM | Dolan Matthew Vincent | SVP Corp. Strategy-Develop | A - Grant | $0.00 | +21.8K | 48.3K | +82% | $0 | |
| 2023-03-10 | 2023-03-08 | DXCM | Selvaraj Shelly Ramasamy | SVP CIO | A - Grant | $0.00 | +10.9K | 61.0K | +22% | $0 | |
| 2023-03-10 | 2023-03-08 | DXCM | Brown Michael Jon | EVP CLO | A - Grant | $0.00 | +21.8K | 70.3K | +45% | $0 | |
| 2023-03-10 | 2023-03-08 | DXCM | Abbey Donald | EVP Gbl Business Services I | A - Grant | $0.00 | +18.8K | 219.7K | +9% | $0 | |
| 2023-03-10 | 2023-03-08 | DXCM | Flynn Paul R | EVP Gbl Revenue | A - Grant | $0.00 | +18.8K | 74.5K | +34% | $0 | |
| 2023-03-10 | 2023-03-08 | DXCM | Leach Jacob Steven | EVP CTO | A - Grant | $0.00 | +25.4K | 306.5K | +9% | $0 | |
| M | 2023-03-06 | 2023-03-06 | DXCM | Leach Jacob Steven | EVP CTO | S - Sale | $114.74 | -18.1K | 288.8K | -6% | -$2.08M |
| 2023-03-06 | 2023-03-06 | DXCM | Dolan Matthew Vincent | SVP Corp. Strategy-Develop | S - Sale | $114.40 | -226 | 26.5K | -0.8% | -$25.9K | |
| M | 2023-03-02 | 2023-03-01 | DXCM | SAYER KEVIN R | Pres CEO, COB of, Dir | S - Sale | $109.94 | -38.5K | 331.3K | -10% | -$4.23M |
| 2023-02-23 | 2023-02-23 | DXCM | Pacelli Steven Robert | EVP Managing Dir Dexcom V | S - Sale | $111.64 | -412 | 136.5K | -0.3% | -$46.0K | |
| 2023-02-22 | 2023-02-22 | DXCM | Sylvain Jereme M | EVP CFO | S - Sale | $114.54 | -2,400 | 64.8K | -4% | -$274.9K | |
| 2023-01-31 | 2023-01-30 | DXCM | Regan Barry J. | EVP Ops | S - Sale | $106.12 | -2,213 | 59.4K | -4% | -$234.8K | |
| M | 2023-01-31 | 2023-01-30 | DXCM | SAYER KEVIN R | Pres CEO, COB of, Dir | S - Sale | $106.15 | -56.8K | 369.8K | -13% | -$6.03M |
| 2023-01-24 | 2023-01-23 | DXCM | Pacelli Steven Robert | EVP Managing Dir Dexcom V | S - Sale | $107.86 | -412 | 136.9K | -0.3% | -$44.4K | |
| 2023-01-24 | 2023-01-20 | DXCM | SAYER KEVIN R | Pres CEO, COB of, Dir | S - Sale | $105.75 | -45.6K | 426.6K | -10% | -$4.82M | |
| 2023-01-20 | 2023-01-18 | DXCM | SAYER KEVIN R | Pres CEO, COB of, Dir | A - Grant | $0.00 | +90.7K | 472.3K | +24% | $0 | |
| 2023-01-20 | 2022-11-03 | DXCM | SAYER KEVIN R | Pres CEO, COB of, Dir | G - Gift | $0.00 | -10.0K | 381.5K | -3% | $0 | |
| 2022-12-27 | 2022-12-23 | DXCM | Pacelli Steven Robert | EVP Managing Dir Dexcom V | S - Sale | $112.57 | -412 | 137.3K | -0.3% | -$46.4K | |
| 2022-12-08 | 2022-12-08 | DXCM | Flynn Paul R | EVP Gbl Revenue | S - Sale | $123.50 | -8,988 | 55.7K | -14% | -$1.11M | |
| 2022-11-22 | 2022-11-21 | DXCM | Regan Barry J. | EVP Ops | D - Sale to Iss | $112.62 | -3,781 | 61.6K | -6% | -$425.8K | |
| 2022-11-22 | 2022-11-21 | DXCM | Stern Sadie | EVP Chief Human Resources Offi | D - Sale to Iss | $112.62 | -3,844 | 68.4K | -5% | -$432.9K | |
| 2022-11-22 | 2022-11-21 | DXCM | Sylvain Jereme M | EVP CFO | S - Sale | $112.62 | -2,400 | 67.2K | -3% | -$270.3K | |
| 2022-11-14 | 2022-11-08 | DXCM | Naganathan Girish | EVP CTO | A - Grant | $0.00 | +31.4K | 31.4K | New | $0 | |
| 2022-09-12 | 2022-09-08 | DXCM | Selvaraj Shelly Ramasamy | SVP CIO | A - Grant | $0.00 | +4,051 | 49.9K | +9% | $0 | |
| 2022-09-06 | 2022-09-01 | DXCM | Dolan Matthew Vincent | SVP Corp. Strategy-Develop | S - Sale | $81.63 | -5 | 26.5K | -0.0% | -$408.15 | |
| 2022-08-24 | 2022-08-23 | DXCM | Pacelli Steven Robert | EVP Managing Dir Dexcom V | S - Sale | $84.21 | -1,000 | 137.7K | -0.7% | -$84.2K | |
| 2022-07-25 | 2022-07-25 | DXCM | Pacelli Steven Robert | EVP Managing Dir Dexcom V | S - Sale | $83.07 | -1,000 | 138.7K | -0.7% | -$83.1K | |
| 2022-06-27 | 2022-06-23 | DXCM | Pacelli Steven Robert | EVP Managing Dir Dexcom V | S - Sale | $72.55 | -1,000 | 139.7K | -0.7% | -$72.5K | |
| 2022-06-06 | 2022-06-06 | DXCM | Sylvain Jereme M | EVP CFO | S - Sale | $301.57 | -600 | 17.4K | -3% | -$180.9K | |
| 2022-05-25 | 2022-05-24 | DXCM | Pacelli Steven Robert | EVP Managing Dir Dexcom V | S - Sale | $296.33 | -250 | 35.2K | -0.7% | -$74.1K | |
| 2022-05-23 | 2022-05-20 | DXCM | Heller Bridgette P | Dir | A - Grant | $0.00 | +988 | 5,355 | +23% | $0 | |
| I | 2022-05-23 | 2022-05-19 | DXCM | AUGUSTINOS NICHOLAS | Dir | J - Other | $0.00 | +918 | 8,510 | +12% | $0 |
| 2022-05-23 | 2022-05-19 | DXCM | AUGUSTINOS NICHOLAS | Dir | J - Other | $0.00 | -918 | 0 | -100% | $0 | |
| 2022-05-23 | 2022-05-20 | DXCM | AUGUSTINOS NICHOLAS | Dir | A - Grant | $0.00 | +994 | 994 | New | $0 | |
| 2022-05-23 | 2022-05-19 | DXCM | KAHN BARBARA | Dir | J - Other | $0.00 | -918 | 0 | -100% | $0 | |
| 2022-05-23 | 2022-05-20 | DXCM | KAHN BARBARA | Dir | A - Grant | $0.00 | +994 | 994 | New | $0 | |
| I | 2022-05-23 | 2022-05-19 | DXCM | KAHN BARBARA | Dir | J - Other | $0.00 | +918 | 3,918 | +31% | $0 |
| I | 2022-05-23 | 2022-05-19 | DXCM | SKYLER JAY S | Dir | J - Other | $0.00 | +900 | 14.9K | +6% | $0 |
| 2022-05-23 | 2022-05-20 | DXCM | SKYLER JAY S | Dir | A - Grant | $0.00 | +969 | 969 | New | $0 | |
| 2022-05-23 | 2022-05-19 | DXCM | SKYLER JAY S | Dir | J - Other | $0.00 | -900 | 0 | -100% | $0 | |
| 2022-05-23 | 2022-05-19 | DXCM | ALTMAN STEVEN R | Dir | J - Other | $0.00 | -910 | 0 | -100% | $0 | |
| 2022-05-23 | 2022-05-20 | DXCM | ALTMAN STEVEN R | Dir | A - Grant | $0.00 | +979 | 979 | New | $0 | |
| I | 2022-05-23 | 2022-05-19 | DXCM | ALTMAN STEVEN R | Dir | J - Other | $0.00 | +910 | 14.7K | +7% | $0 |
| M | 2022-05-23 | 2021-08-11+ | DXCM | Dahut Karen M | Dir | J - Other | $0.00 | -1,305 | 773 | -63% | $0 |
| 2022-05-23 | 2022-05-20 | DXCM | Dahut Karen M | Dir | A - Grant | $0.00 | +987 | 1,760 | +128% | $0 | |
| MI | 2022-05-23 | 2021-08-11+ | DXCM | Dahut Karen M | Dir | J - Other | $0.00 | +1,305 | 1,305 | New | $0 |
| I | 2022-05-23 | 2022-05-19 | DXCM | TOPOL ERIC | Dir | J - Other | $0.00 | +919 | 92.8K | +1% | $0 |
| 2022-05-23 | 2022-05-20 | DXCM | TOPOL ERIC | Dir | A - Grant | $0.00 | +988 | 988 | New | $0 | |
| 2022-05-23 | 2022-05-19 | DXCM | TOPOL ERIC | Dir | J - Other | $0.00 | -919 | 0 | -100% | $0 | |
| I | 2022-05-23 | 2022-05-19 | DXCM | FOLETTA MARK G | Dir | J - Other | $0.00 | +1,054 | 13.7K | +8% | $0 |
| 2022-05-23 | 2022-05-20 | DXCM | FOLETTA MARK G | Dir | A - Grant | $0.00 | +1,122 | 1,122 | New | $0 | |
| 2022-05-23 | 2022-05-19 | DXCM | FOLETTA MARK G | Dir | J - Other | $0.00 | -1,054 | 0 | -100% | $0 | |
| 2022-05-23 | 2022-05-19 | DXCM | Collins Richard Alexander | Dir | J - Other | $0.00 | -910 | 0 | -100% | $0 | |
| I | 2022-05-23 | 2022-05-19 | DXCM | Collins Richard Alexander | Dir | J - Other | $0.00 | +910 | 8,114 | +13% | $0 |
| 2022-05-23 | 2022-05-20 | DXCM | Collins Richard Alexander | Dir | A - Grant | $0.00 | +987 | 987 | New | $0 | |
| 2022-05-23 | 2022-05-20 | DXCM | Malady Kyle | Dir | A - Grant | $0.00 | +979 | 3,161 | +45% | $0 | |
| 2022-05-10 | 2022-05-09 | DXCM | Patterson Chad | EVP Gbl Marketing | S - Sale | $342.77 | -777 | 13.7K | -5% | -$266.3K | |
| 2022-04-27 | 2022-04-25 | DXCM | Pacelli Steven Robert | Managing Dir, Dexcom Ventures | S - Sale | $439.94 | -250 | 35.4K | -0.7% | -$110.0K | |
| 2022-04-13 | 2022-04-11 | DXCM | Patterson Chad | EVP, Gbl Marketing | S - Sale | $498.75 | -776 | 14.5K | -5% | -$387.0K | |
| 2022-03-30 | 2022-03-29 | DXCM | Regan Barry J. | EVP Gbl Ops | S - Sale | $500.00 | -1,106 | 16.3K | -6% | -$553.0K | |
| 2022-03-24 | 2022-03-23 | DXCM | Pacelli Steven Robert | Managing Dir, Dexcom Ventures | S - Sale | $459.98 | -250 | 35.7K | -0.7% | -$115.0K | |
| M | 2022-03-17 | 2022-03-15+ | DXCM | Dolan Matthew Vincent | SVP Corp. Development | S - Sale | $424.68 | -2,186 | 7,804 | -22% | -$928.4K |
| M | 2022-03-17 | 2022-03-15 | DXCM | SAYER KEVIN R | COB, CEO, Pres, Dir | S - Sale | $409.77 | -3,000 | 98.2K | -3% | -$1.23M |
| 2022-03-14 | 2022-03-10 | DXCM | Patterson Chad | EVP, Gbl Marketing | S - Sale | $401.27 | -776 | 15.2K | -5% | -$311.4K | |
| 2022-03-14 | 2022-03-10 | DXCM | Selvaraj Shelly Ramasamy | SVP CIO | S - Sale | $401.27 | -2,366 | 11.5K | -17% | -$949.4K | |
| 2022-03-10 | 2022-03-08 | DXCM | Selvaraj Shelly Ramasamy | SVP CIO | A - Grant | $0.00 | +2,889 | 15.7K | +23% | $0 | |
| M | 2022-03-10 | 2022-03-09 | DXCM | Selvaraj Shelly Ramasamy | SVP CIO | D - Sale to Iss | $406.06 | -1,865 | 15.2K | -11% | -$757.3K |
| 2022-03-10 | 2022-03-09 | DXCM | Regan Barry J. | EVP Gbl Ops | D - Sale to Iss | $406.06 | -661 | 17.5K | -4% | -$268.4K | |
| 2022-03-10 | 2022-03-08 | DXCM | Regan Barry J. | EVP Gbl Ops | A - Grant | $0.00 | +4,984 | 18.1K | +38% | $0 | |
| M | 2022-03-10 | 2022-03-09 | DXCM | SAYER KEVIN R | COB, CEO, Pres, Dir | D - Sale to Iss | $406.06 | -9,985 | 107.7K | -8% | -$4.05M |
| 2022-03-10 | 2022-03-08 | DXCM | SAYER KEVIN R | COB, CEO, Pres, Dir | A - Grant | $0.00 | +16.3K | 110.9K | +17% | $0 | |
| M | 2022-03-10 | 2022-03-09 | DXCM | Pacelli Steven Robert | Managing Dir, Dexcom Ventures | D - Sale to Iss | $406.06 | -3,429 | 38.0K | -8% | -$1.39M |
| 2022-03-10 | 2022-03-08 | DXCM | Pacelli Steven Robert | Managing Dir, Dexcom Ventures | A - Grant | $0.00 | +4,984 | 39.4K | +15% | $0 | |
| M | 2022-03-10 | 2022-03-09 | DXCM | Sylvain Jereme M | EVP, CFO | D - Sale to Iss | $406.06 | -1,951 | 18.0K | -10% | -$792.2K |
| 2022-03-10 | 2022-03-08 | DXCM | Sylvain Jereme M | EVP, CFO | A - Grant | $0.00 | +5,297 | 20.0K | +36% | $0 | |
| M | 2022-03-10 | 2022-03-09 | DXCM | Patterson Chad | EVP, Gbl Marketing | D - Sale to Iss | $406.06 | -1,821 | 17.6K | -9% | -$739.4K |
| 2022-03-10 | 2022-03-08 | DXCM | Patterson Chad | EVP, Gbl Marketing | A - Grant | $0.00 | +5,297 | 17.8K | +42% | $0 | |
| 2022-03-10 | 2022-03-08 | DXCM | Brown Michael Jon | EVP CLO | A - Grant | $0.00 | +12.0K | 12.0K | New | $0 | |
| M | 2022-03-10 | 2022-03-09 | DXCM | Balo Andrew K | EVP, Gbl Medical Affairs | D - Sale to Iss | $406.06 | -3,430 | 16.6K | -17% | -$1.39M |
| 2022-03-10 | 2022-03-08 | DXCM | Balo Andrew K | EVP, Gbl Medical Affairs | A - Grant | $0.00 | +4,984 | 19.0K | +35% | $0 | |
| 2022-03-10 | 2022-03-08 | DXCM | Stern Sadie | EVP Chief Human Resources Off | A - Grant | $0.00 | +5,297 | 18.8K | +39% | $0 | |
| 2022-03-10 | 2022-03-09 | DXCM | Stern Sadie | EVP Chief Human Resources Off | D - Sale to Iss | $406.06 | -701 | 18.1K | -4% | -$284.6K | |
| M | 2022-03-10 | 2022-03-09 | DXCM | Flynn Paul R | EVP Gbl Revenue | D - Sale to Iss | $406.06 | -2,967 | 17.0K | -15% | -$1.20M |
| 2022-03-10 | 2022-03-08 | DXCM | Flynn Paul R | EVP Gbl Revenue | A - Grant | $0.00 | +5,297 | 19.1K | +38% | $0 | |
| M | 2022-03-10 | 2022-03-09 | DXCM | Leach Jacob Steven | EVP CTO | D - Sale to Iss | $406.06 | -4,273 | 74.7K | -5% | -$1.74M |
| 2022-03-10 | 2022-03-08 | DXCM | Leach Jacob Steven | EVP CTO | A - Grant | $0.00 | +6,741 | 79.0K | +9% | $0 | |
| M | 2022-03-10 | 2022-03-09 | DXCM | Shrishrimal Sumi | SVP CRO | D - Sale to Iss | $406.06 | -1,357 | 14.6K | -8% | -$551.0K |
| 2022-03-10 | 2022-03-08 | DXCM | Shrishrimal Sumi | SVP CRO | A - Grant | $0.00 | +2,889 | 15.1K | +24% | $0 | |
| M | 2022-03-10 | 2022-03-09 | DXCM | Dolan Matthew Vincent | SVP Corp. Development | D - Sale to Iss | $406.06 | -1,615 | 8,820 | -15% | -$655.8K |
| 2022-03-10 | 2022-03-08 | DXCM | Dolan Matthew Vincent | SVP Corp. Development | A - Grant | $0.00 | +2,889 | 10.4K | +38% | $0 | |
| M | 2022-03-10 | 2022-03-09 | DXCM | Abbey Donald | EVP Quality Regulatory Affairs | D - Sale to Iss | $406.06 | -3,429 | 50.2K | -6% | -$1.39M |
| 2022-03-10 | 2022-03-08 | DXCM | Abbey Donald | EVP Quality Regulatory Affairs | A - Grant | $0.00 | +4,984 | 53.7K | +10% | $0 |
Purchase Sale Sale after option exercise All abbreviations